NCT02096640

Brief Summary

The main purpose of this study is to examine if there are differences in postoperative inflammation following percutaneous dilatation tracheostomy versus surgical tracheostomy in intensive care unit patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2014

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

March 13, 2014

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 26, 2014

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

March 26, 2014

Status Verified

March 1, 2014

Enrollment Period

4.8 years

First QC Date

March 13, 2014

Last Update Submit

March 23, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in inflammation markers in plasma

    Plasma samples will be taken preoperative and 24 hours after the start of tracheostomy. The levels of TNF-alpha, IL-6 and IL-10 will be measured.

    Preoperative and 24 hours after the start of surgery

Secondary Outcomes (1)

  • Postoperative complications

    Until discharge from the ICU

Other Outcomes (1)

  • Physical function

    One week after tracheostomy

Study Arms (2)

Percutaneous dilatation tracheostomy: Smiths Medical

ACTIVE COMPARATOR

Type of surgical teqnique for tracheostomy: Percutaneous dilatation tracheostomy. The set for the tracheostomy is bought from Smiths Medical TM.

Procedure: Type of surgical teqnique for tracheostomy

Open surgery tracheostomy

ACTIVE COMPARATOR

Type of surgical teqnique for tracheostomy: Open surgical tracheostomy

Procedure: Type of surgical teqnique for tracheostomy

Interventions

Open surgery tracheostomyPercutaneous dilatation tracheostomy: Smiths Medical

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Children under 18 years, pregnancy and participants with anatomical defects that exclude them from percutaneous dilatation tracheostomy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Intensivvårdsavdelningen på Mälarsjukhuset

Eskilstuna, Sörmland, 631 88, Sweden

Location

MeSH Terms

Conditions

Inflammation

Interventions

Tracheostomy

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Airway ManagementTherapeuticsOstomySurgical Procedures, OperativeOtorhinolaryngologic Surgical ProceduresThoracic Surgical Procedures

Study Officials

  • Markus Castegren, MD, PhD

    Centre for Clinical Research, Uppsala University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ulrika H Skoog, PTh

CONTACT

Markus Castegren, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Med. dr.

Study Record Dates

First Submitted

March 13, 2014

First Posted

March 26, 2014

Study Start

March 1, 2014

Primary Completion

December 1, 2018

Study Completion

December 1, 2019

Last Updated

March 26, 2014

Record last verified: 2014-03

Locations